Home
>
National Drug Code (NDC)
>
SELZENTRY
SELZENTRY - 49702-216-18 - (maraviroc)
Drug Information of SELZENTRY
| Product NDC: | 49702-216 |
| Proprietary Name: | SELZENTRY |
| Non Proprietary Name: | maraviroc |
| Active Ingredient(s): | 300 mg/1 & nbsp; maraviroc |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SELZENTRY
| Product NDC: | 49702-216 |
| Labeler Name: | ViiV Healthcare Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022128 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100901 |
Package Information of SELZENTRY
| Package NDC: | 49702-216-18 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (49702-216-18) |
NDC Information of SELZENTRY
| NDC Code | 49702-216-18 |
| Proprietary Name | SELZENTRY |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (49702-216-18) |
| Product NDC | 49702-216 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | maraviroc |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100901 |
| Marketing Category Name | NDA |
| Labeler Name | ViiV Healthcare Company |
| Substance Name | MARAVIROC |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
